Quick Answer
ARTELO BIOSCIENCES, INC. reported R&D Expense of $5.42 million for fiscal year 2025.
ARTELO BIOSCIENCES, INC. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $5.42M | -9.5% |
| 2024 | $5.99M | +5.2% |
| 2023 | $5.70M | +31.7% |
| 2022 | $4.32M | +14.3% |
| 2021 | $3.78M | +33.3% |
| 2021 | $2.84M | +47.9% |
| 2020 | $1.92M | +75.7% |
| 2019 | $1.09M | -12.6% |
| 2018 | $1.25M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.27M | +292.3% | -31.9% |
| June 30, 2025 | $1.87M | +11.0% | +35.2% |
| March 31, 2025 | $1.38M | -8.2% | +325.8% |
| September 30, 2024 | $325.0K | -79.5% | -80.7% |
| June 30, 2024 | $1.69M | +124.1% | +11.8% |
| March 31, 2024 | $1.51M | +22.0% | -4.9% |
| September 30, 2023 | $1.58M | +47.0% | +110.8% |
| June 30, 2023 | $752.0K | -28.8% | -39.1% |
- ARTELO BIOSCIENCES, INC. showed a decrease of -9.5% in R&D Expense compared to the prior fiscal year.
- Over the 2018–2025 period, ARTELO BIOSCIENCES, INC.’s r&d expense has grown by 333.9% (from $1.25 million to $5.42 million).
- The most recent figure is from ARTELO BIOSCIENCES, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: